Veterinary Medicines

Marfloxin 20 mg/ml solution for injection for calves, pigs, dogs and cats

Not authorised
  • Marbofloxacin
Download as PDF

Product identification

Medicine name:
Marfloxin 20 mg/ml solution for injection for calves, pigs, dogs and cats
Marfloxin 20 mg/ml solution for injection for calves, pigs, dogs and cats
Active substance:
  • Marbofloxacin
Target species:
  • Cattle
  • Pig
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Marbofloxacin
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        4
        day
    • Pig
      • Meat and offal
        2
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        4
        day
    • Dog
    • Cat
  • Subcutaneous use
    • Cattle
      • Meat and offal
        4
        day
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA93
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Ireland
Package description:
  • 20 ml amber glass vial (Ph. Eur. type II) sealed with a bromobutyl rubber stopper and aluminium closure packaged in an outer carton.
  • 50 ml amber glass vial (Ph. Eur. type II) sealed with a bromobutyl rubber stopper and aluminium closure packaged in an outer carton.
  • 100 ml amber glass vial (Ph. Eur. type II) sealed with a bromobutyl rubber stopper and aluminium closure packaged in an outer carton.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10774/014/001
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0262/001

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."